WHO ICTRP trial
Clinical evaluation of antigen-specific chemokines CXCL9 in the diagnosis of…
ChiCTR2400082055 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400082055 |
|---|---|
| Public title | Clinical evaluation of antigen-specific chemokines CXCL9 in the diagnosis of tuberculosis infection |
| Scientific title | Clinical evaluation of antigen-specific chemokines CXCL9 in the diagnosis of tuberculosis infection |
| Primary sponsor | Beijing Chest Hospital Affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | tuberculosis infection |
| Interventions | Gold Standard:The confirmed cases and clinically diagnosed cases of tuberculosis in the "Diagnosis of Tuberculosis" standard (WS288-2017) were used as the gold standard for TB diagnosis; Culture and identification of Mycobacterium… |
| Registration date | Mar 19, 2024 |
| Target size | Target condition:400;Difficult condition:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: